sacituzumab govitecan,Pembrolizumab,Avelumab,Zimberelimab,Domvanalimab
Gilead Sciences,Merck,Pfizer,Arcus Biosciences,Otsuka
['gu ', 'urothelial', 'urothelial carcinoma', 'trophy,u-01', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)']
 , md, professor of medicine and urology at , overviews the trophy-u-01 study for platinum-ineligible patients with metastatic urothelial carcinoma who have progressed on checkpoint inhibitor therapy in our interview from #gu23: 
GU Oncology Now delivers the latest news in therapeutics, clinical trials, conference coverage, and important advancements in the genitourinary oncology field.